Oura to List on Nasdaq in September Move Valuing Firm Above $11 Billion

HELSINKI — Oura, the Finnish manufacturer of health-tracking smart rings, announced plans to list its shares on the Nasdaq stock exchange in New York. The company filed for an initial public offering scheduled for September 4, 2026, aiming to raise capital to fuel expansion of its high-margin consumer wearable business. The move is expected to value the private firm at more than $11 billion.

The listing marks a significant milestone for Oura, which has established itself as a leader in the direct-to-consumer health technology sector. Since launching its first product in 2015, the company has built a reputation for monitoring sleep quality, heart rate variability, and temperature trends without relying on traditional smartphone screens. The decision to go public comes as the wearable market intensifies competition among major tech giants and niche players alike.

By accessing public markets, Oura seeks to secure funding necessary for scaling operations, enhancing its proprietary algorithms, and broadening its global footprint. The company's financial structure has been characterized by strong margins, driven by a subscription model that pairs hardware sales with ongoing data analysis services. Industry analysts note that the $11 billion valuation reflects investor confidence in the growing demand for continuous health monitoring tools.

The Nasdaq listing will make Oura one of the few pure-play health tracking companies to trade on a major U.S. exchange. The offering is set to take place in New York, where the company intends to deepen its presence in the North American market, its largest revenue generator. While the company has not disclosed specific details regarding the number of shares to be sold or the exact price range, the filing indicates a strategic shift from private growth to public market accountability.

As the September 4 deadline approaches, attention remains on how the company will navigate the transition from a privately held entity to a publicly traded corporation. Questions persist regarding the allocation of proceeds and whether the firm will maintain its current leadership structure post-IPO. Additionally, investors are watching closely to see if the high valuation can be sustained in a volatile market environment where consumer discretionary spending remains a key variable.

The announcement was made on Wednesday, setting the stage for a formal roadshow with institutional investors ahead of the trading debut. Oura's entry into the public sphere is expected to bring increased scrutiny to its data privacy practices and long-term growth projections as it competes with established players in the digital health ecosystem.